Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.

MLA

Højen, Anette Arbjerg, et al. “Disparities in Oral Anticoagulation Initiation in Patients with Schizophrenia and Atrial Fibrillation: A Nationwide Cohort Study.” British Journal of Clinical Pharmacology, vol. 88, no. 8, Aug. 2022, pp. 3847–55. EBSCOhost, https://doi.org/10.1111/bcp.15337.

APA

Højen, A. A., Nielsen, P. B., Riahi, S., Jensen, M., Lip, G. Y. H., Larsen, T. B., & Søgaard, M. (2022). Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study. British Journal of Clinical Pharmacology, 88(8), 3847–3855. https://doi.org/10.1111/bcp.15337

Chicago

Højen, Anette Arbjerg, Peter Brønnum Nielsen, Sam Riahi, Martin Jensen, Gregory Y H Lip, Torben Bjerregaard Larsen, and Mette Søgaard. 2022. “Disparities in Oral Anticoagulation Initiation in Patients with Schizophrenia and Atrial Fibrillation: A Nationwide Cohort Study.” British Journal of Clinical Pharmacology 88 (8): 3847–55. doi:10.1111/bcp.15337.